1. Home
  2. SCLX vs OCC Comparison

SCLX vs OCC Comparison

Compare SCLX & OCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • OCC
  • Stock Information
  • Founded
  • SCLX 2011
  • OCC 1983
  • Country
  • SCLX United States
  • OCC United States
  • Employees
  • SCLX N/A
  • OCC N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • OCC Telecommunications Equipment
  • Sector
  • SCLX Health Care
  • OCC Industrials
  • Exchange
  • SCLX Nasdaq
  • OCC Nasdaq
  • Market Cap
  • SCLX 35.7M
  • OCC 40.9M
  • IPO Year
  • SCLX N/A
  • OCC 1996
  • Fundamental
  • Price
  • SCLX $18.87
  • OCC $5.65
  • Analyst Decision
  • SCLX Strong Buy
  • OCC
  • Analyst Count
  • SCLX 3
  • OCC 0
  • Target Price
  • SCLX $367.50
  • OCC N/A
  • AVG Volume (30 Days)
  • SCLX 324.6K
  • OCC 60.1K
  • Earning Date
  • SCLX 08-13-2025
  • OCC 09-10-2025
  • Dividend Yield
  • SCLX N/A
  • OCC N/A
  • EPS Growth
  • SCLX N/A
  • OCC N/A
  • EPS
  • SCLX N/A
  • OCC N/A
  • Revenue
  • SCLX $44,236,000.00
  • OCC $68,999,601.00
  • Revenue This Year
  • SCLX $89.26
  • OCC N/A
  • Revenue Next Year
  • SCLX $203.95
  • OCC N/A
  • P/E Ratio
  • SCLX N/A
  • OCC N/A
  • Revenue Growth
  • SCLX N/A
  • OCC 5.77
  • 52 Week Low
  • SCLX $3.60
  • OCC $2.02
  • 52 Week High
  • SCLX $45.15
  • OCC $7.00
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 63.34
  • OCC 58.07
  • Support Level
  • SCLX $15.61
  • OCC $5.01
  • Resistance Level
  • SCLX $22.01
  • OCC $5.40
  • Average True Range (ATR)
  • SCLX 2.21
  • OCC 0.44
  • MACD
  • SCLX -0.14
  • OCC -0.06
  • Stochastic Oscillator
  • SCLX 62.35
  • OCC 51.61

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About OCC Optical Cable Corporation

Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.

Share on Social Networks: